Cumberland Pharmaceuticals

  • Venture Exits Still Anemic In Third Quarter, Down Nearly 50 Percent (Charts)

    Despite a couple large IPOs (LogMein and A123Systems) and a steady but tempered flow of mergers and acquisitions, financial exits for venture-backed companies remained anemic in the third quarter of 2009. Data released by both Dow Jones VentureSource and the National Venture Capital Association/Thomson Reuters show declines in both M&A and IPO dollars. VentureSource counts $2.9 billion… Read More